The Penn Ovarian Cancer Research Center (OCRC) is a dedicated research institute based in Philadelphia, Pennsylvania, focused on advancing the understanding and treatment of ovarian cancer. Situated in the Biomedical Research Building, the center plays a pivotal role in conducting cutting-edge scientific studies aimed at uncovering the underlying mechanisms of this complex disease. By concentrating on ovarian cancer, the institute contributes valuable insights that support the development of new diagnostic tools and therapeutic strategies.
This research institute collaborates with a broad network of medical professionals, scientists, and academic institutions to enhance the scope and impact of its work. The center’s location in Philadelphia allows it to leverage the city’s robust medical research environment, fostering an atmosphere of innovation and interdisciplinary cooperation. Its team employs a variety of research methodologies, including molecular biology, genetics, and clinical trials, to address critical questions about ovarian cancer progression and resistance to treatment.
In addition to laboratory research, the Penn Ovarian Cancer Research Center places emphasis on translating scientific discoveries into practical applications that can improve patient outcomes. This includes efforts to identify biomarkers for early detection and to develop personalized treatment plans based on individual patient profiles. The center’s commitment to rigorous scientific inquiry supports ongoing progress in the fight against ovarian cancer, providing hope for more effective therapies in the future.
The institute’s contact number is 215-746-3973, where inquiries regarding research activities or collaborative opportunities can be directed. While it primarily functions as a hub for scientific investigation, the Penn Ovarian Cancer Research Center also serves as a resource for the local and wider medical community, fostering knowledge exchange and contributing to the broader goal of combating ovarian cancer through research-driven solutions.


































